S. Burger

发表

Retroviral transduction and expansion of peripheral blood lymphocytes for the treatment of mucopolysaccharidosis type II, Hunter's syndrome

D. Stroncek, A. Hubel, C. Whitley, 1999, Transfusion.

Retroviral transduction of peripheral blood leukocytes in a hollow‐ fiber bioreactor

D. Stroncek, C. Whitley, D. Stroncek, 1997, Transfusion.

Concise Review: Guidance in Developing Commercializable Autologous/Patient‐Specific Cell Therapy Manufacturing

H. Brandwein, A. Campbell, M. Armant, 2013, Stem cells translational medicine.

Current regulatory issues in cell and tissue therapy.

S. Burger, 2003, Cytotherapy.

BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.

S. Heimfeld, C. Verfaillie, G. Dewald, 1996, Blood.

GTP/GMP Cell Engineering for Cell and Gene Therapies CONFERENCE EXCLUSIVE

S. Burger, 2003 .

Hyaluronan Synthase Elevation in Metastatic Prostate Carcinoma Cells Correlates with Hyaluronan Surface Retention, a Prerequisite for Rapid Adhesion to Bone Marrow Endothelial Cells*

T. Oegema, M. Simpson, J. Reiland, 2001, The Journal of Biological Chemistry.

Expression of human glycophorin A in wild type and glycosylation-deficient Chinese hamster ovary cells. Role of N- and O-linked glycosylation in cell surface expression.

A. Remaley, L. Litzky, M. Fukuda, 1991, The Journal of biological chemistry.

Cellular Engineering of HSV-tk Transduced, Expanded T Lymphocytes for Graft-versus-Host Disease Management

D. Kadidlo, P. Orchard, S. Burger, 2003, Acta Haematologica.

Retroviral-mediated transfer of the iduronate-2-sulfatase gene into lymphocytes for treatment of mild Hunter syndrome (mucopolysaccharidosis type II).

R. Latchaw, R. McIvor, B. Blazar, 1996, Human gene therapy.

Non‐frozen preservation of umbilical cord blood

J. McCullough, S. Burger, Ulrike F. Koenigbauer, 2002, Transfusion.

Umbilical Cord Blood Stem Cells

S. Burger, 2001 .

Improved progenitor assay standardization using peripheral blood progenitor cells from a donor treated with granulocyte–colony‐stimulating factor

D. Kadidlo, J. McCullough, S. Burger, 1999, Transfusion.

Development of an infusible-grade solution for non-cryopreserved hematopoietic cell storage.

A. Hubel, J. McCullough, S. Burger, 1999, Cytotherapy.

Noncryopreserved Bone Marrow Storage in STM-Sav, an Infusible-Grade Cell Storage Solution

A. Hubel, J. McCullough, S. Burger, 2002 .

The glycosphingolipid composition of the human hepatoma cell line,Hep-G2.

S. Spitalnik, S. Burger, P. Spitalnik, 1989, Archives of biochemistry and biophysics.

Concentration of citrate anticoagulant in peripheral blood progenitor cell collections

D. Stroncek, D. Stroncek, S. Burger, 1996, Transfusion.

Stable expression of rabies virus glycoprotein in Chinese hamster ovary cells.

R. Muschel, A. Remaley, S. Spitalnik, 1991, The Journal of general virology.

Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry.

Christopher A Bravery, Jessica Carmen, Timothy Fong, 2013, Cytotherapy.

HPC viability measurement: trypan blue versus acridine orange and propidium iodide

J. McCullough, K. Mascotti, S. Burger, 2000, Transfusion.

Making the grade: untangling the myths of raw materials used for the manufacture of cell- & gene-based medicinal products

Scott R. Burger, Sarah Robinson, Christopher A. Bravery, 2018 .

GMP Facilities for Clinical Cell Therapy Product Manufacturing: A Brief Review of Requirements and Design Considerations

Babak Arjmand, Hamid Reza Aghayan, Scott R. Burger, 2016 .

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial

D. Vesole, D. Weisdorf, B. Blazar, 2003, Bone Marrow Transplantation.

National Blood Foundation 2021 Research and Development summit: Discovery, innovation, and challenges in advancing blood and biotherapies

B. Custer, J. Holmberg, S. Spitalnik, 2022, Transfusion.

Clinical-scale selection of anti-CD3/CD28-activated T cells after transduction with a retroviral vector expressing herpes simplex virus thymidine kinase and truncated nerve growth factor receptor.

J. Wagner, B. Levine, Jeffrey S. Miller, 2002, Human gene therapy.

Validation of short‐term handling and storage conditions for marrow and peripheral blood stem cell products

J. Ritz, S. Spellman, C. Vierra-Green, 2011, Transfusion.

Cell Processing for Clinical Trials and Commercial Manufacture

H. Prince, S. Burger, N. Boyce, 2004 .

High peripheral blood progenitor cell counts enable autologous backup before stem cell transplantation for malignant infantile osteopetrosis.

A. Flanagan, J. Moppett, P. Orchard, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Induced cell surface expression of functional α2β1 integrin during megakaryocytic differentiation of K562 leukemic cells

S. Santoro, M. Zutter, S. Burger, 1992 .

Developing assays to address identity, potency, purity and safety: cell characterization in cell therapy process development.

Scott R Burger, Jon A Rowley, M. Mccaman, 2012, Regenerative medicine.

Increased lymphoblast-like cells following umbilical cord blood stem cell transplantation do not predict recurrent acute leukemia

J Wagner, B. Hirsch, R. Mcglennen, 2002, Leukemia.

Design and operation of a current good manufacturing practices cell-engineering laboratory.

S R Burger, S. Burger, 2000, Cytotherapy.

Induced cell surface expression of functional alpha 2 beta 1 integrin during megakaryocytic differentiation of K562 leukemic cells.

S. Santoro, M. Zutter, S. Burger, 1992, Experimental cell research.

Integration of concurrent collection of plasma into a plateletpheresis program

S. Burger, B. Thomas, J. Grishaber, 1994, Journal of clinical apheresis.